Opportunity Mapping News Today

/PRNewswire/ -- The "Egypt International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value & Volume, Inbound and Outbound...

Dublin, Aug. 03, 2022 (GLOBE NEWSWIRE) -- The "Global Microbiome Therapeutics Market - A Global and Regional Analysis: Focus on Target Therapies, Region...

/PRNewswire/ -- The "Global Microbiome Therapeutics Market - A Global and Regional Analysis: Focus on Target Therapies, Region (10 Countries), and Competitive...

Share this article Share this article ResearchAndMarkets.coms offering. This report highlights that the market is projected to reach $40.6 billion by 2030. The study also highlights that the market is set to witness a CAGR of 6.09% during the period 2020-2030. The market is driven by the need for the development of an advanced solution based on various technologies such as next-generation sequencing, in-situ hybridization, and polymerase chain reaction for cancer research in various application...

The Strategic Imperative 8 Growth Opportunities Fuel the Growth Pipeline Engine 2. Growth Opportunity Analysis - Digital Pathology Market Digital Pathology Market Scope of Analysis Digital Pathology Market Segmentation by Product Digital Pathology Market Segmentation by Region Key Growth Metrics for the Digital Pathology Market Distribution Channels for Digital Pathology Solutions Growth Drivers for the Digital Pathology Market Growth Restraints for the Digital Pathology Market 3. Market Foreca...

Key Companies Profiled $3,188.9 Million Healthcare experts have found the single-cell multi-omics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 21.16% during the forecast period, 2020-2025. The market is driven by the need for the development of an advanced solution based on single-cell technology for clinical research in various applications such as cancer, rare disease, cell biology, and synthetic biology, among others. The market is favored by...

Please note that the posts on The Blogs are contributed by third parties. The opinions, facts and any media content in them are presented solely by the authors, and neither The Times of Israel nor its partners assume any responsibility for them. Please contact us in case of abuse. In case of abuse, Image: Unsplash Whether open innovation and venture capital activities should be executed in close cooperation or separately largely depends on the organization. For more mature, innovative comp...

Global Bioengineered Skin Substitutes Market to Reach $4.33 Billion by 2030 The bioengineered skin substitutes market is currently at a blooming phase, with the presence of various juggernauts such as AbbVie, Inc., Integra LifeSciences Corporation, Smith & Nephew plc, and Stryker Corporation, and other medium and small-medium enterprises that are offering a wide range of bioengineered skin substitutes products in the market. Several companies are attempting to enter the market and sustain thems...